Controlant, a leading innovator in the pharmaceutical supply chain sector, is excited to announce that it has successfully raised $35 million in its latest funding round. This significant investment will be instrumental in advancing our commitment to delivering zero-waste supply chains for our partners and the planet, underscoring our dedication to digitalization, automation, and transformation efforts within the pharma industry. Our cutting-edge real-time visibility platform, command center, and advanced IoT devices have become indispensable tools for many of the world’s foremost pharmaceutical and logistics companies, revolutionizing their operations while making them more reliable, cost-effective, and sustainable. This influx of capital will enable Controlant to further enhance our services, expand our technology capabilities, and bolster our global footprint, as we continue to create solutions that ensure life-saving medicines reach more patients, ultimately curing more diseases across the globe. With a workforce of over 430 employees from more than 40 nationalities, we are proud to foster a diverse and dynamic environment that drives innovation and accelerates our mission. As we embark on this exciting journey, we remain committed to building stronger partnerships and delivering impactful solutions that empower health care systems around the world. We look forward to what lies ahead and are grateful to our investors for their support in making this dream a reality.

Controlant Secures $35M Funding to Transform Pharma Supply Chains with Zero-Waste Vision
Get the full Controlant company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
BioStem Technologies
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
$2.5M Unknown
today

Edify Systems
When you're running 10+ stores, the cracks in your operations become expensive. Inconsistent stock levels across sites, manual processes that don't scale, food waste that eats into margins, and zero real time visibility for the ops team. That's what Edify solves. Our AI powered platform gives operations leaders a single system to manage inventory, plan production, and report across their entire estate, whether that's 20 locations or 500. Built in intelligence surfaces the insights that matter, so your team spends less time in spreadsheets and more time running operations. What we cover: Inventory management across all sites. AI driven production planning and prep workflows. Operational reporting and real time visibility. Multi location scalability built in from day one. We work with QSR brands and multi site coffee chains who have outgrown spreadsheets and fragmented systems but need something purpose built for high volume, multi unit operations. If your back of house is holding back your growth, we should talk.
$4.0M Seed
today

Generalist
Generalist is an AI robotics company building general intelligence for the physical world. The founding team includes engineers from OpenAI, Google DeepMind, and Boston Dynamics. The company embraces both large-scale AI and robotics as core to its DNA.
$400.0M Unknown
today

Scotch
From neighborhood stores to destination warehouses, liquor retailers of all sizes have been held back by manual tasks, slow systems and limited business intelligence. So we decided to build something better — smarter software that saves time and improves margins so independent retailers could focus on their customers, not manually managing inventory.
$20.0M Series a
today

Kempfer / K Creative Office
Based in São Paulo, we specialize in social media creation and content, delivering creative solutions that connect, engage, and inspire Com sede em São Paulo, somos especialistas em criação e conteúdo para social media, entregando soluções criativas que conectam, envolvem e inspiram.
$1.3M Unknown
today